Rockwell Medical Inc
RMTI
$7.89-1.62%
End of day · as of Oct 10, 2026, 2:02 AM ET
Mkt cap
$25.68M
EV/Sales
0.34
P/E ratio
N/A
FY2025 Revenue
$69.26M
EPS (H1 2026)
$-0.74
Gross Margin (FY2025)
16.89%
Profit Margin (FY2025)
-7.67%
Beta
N/A
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
Rockwell Medical Inc (RMTI) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported RMTI revenue for 2025-12-31 was $69.3M. Net income was -$5.3M. Revenue was down 31.8% from 2024-12-31 to 2025-12-31. RMTI currently screens at market cap $25.7M.
Use this RMTI research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full RMTI income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Rockwell Medical Inc (RMTI) is a drug manufacturers - specialty & generic company in the Healthcare sector.
Latest cached Rockwell Medical Inc (RMTI) revenue for Dec 31, 2025 was $69.3M. Net income was -$5.3M. Statements: https://lician.com/financials/rmti
Rockwell Medical Inc (RMTI) market capitalization is $25.7M on the latest cached snapshot.
Rockwell Medical Inc (RMTI) cached previous close $8.02; day range $7.89 – $8.03; volume 7,895. Session quote: https://lician.com/quote/rmti